W.E. Gillanders

1.3k total citations · 1 hit paper
6 papers, 1.0k citations indexed

About

W.E. Gillanders is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, W.E. Gillanders has authored 6 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in W.E. Gillanders's work include Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Cells and Metastasis (3 papers). W.E. Gillanders is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Cells and Metastasis (3 papers). W.E. Gillanders collaborates with scholars based in United States, Switzerland and Chile. W.E. Gillanders's co-authors include Simone Muenst, Feng Gao, Savas D. Soysal, S. Peter Goedegebuure, Daniel Oertli, Ellen C. Obermann, Raoul A. Droeser, Paul Zajac, Rosanna Zanetti and Silvio Däster and has published in prestigious journals such as The Journal of Experimental Medicine, British Journal of Cancer and Annals of Oncology.

In The Last Decade

W.E. Gillanders

6 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

2014 462 citations Simone Muenst, Feng Gao et al. Breast Cancer Research and Treatment profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W.E. Gillanders United States	5	826	493	231	145	133	6	1.0k
Felix Klug Germany	8	650 0.8×	616 1.2×	192 0.8×	181 1.2×	76 0.6×	8	1.0k
Nicole M. McLaughlin Australia	12	779 0.9×	925 1.9×	318 1.4×	68 0.5×	81 0.6×	12	1.5k
Nana-Ama A.S. Anang United States	4	973 1.2×	762 1.5×	223 1.0×	162 1.1×	76 0.6×	6	1.2k
Yasuko Tada Japan	6	877 1.1×	691 1.4×	167 0.7×	270 1.9×	103 0.8×	8	1.2k
Ivy X. Chen United States	8	560 0.7×	371 0.8×	238 1.0×	129 0.9×	131 1.0×	10	947
Shiping Jiao China	6	917 1.1×	401 0.8×	391 1.7×	229 1.6×	127 1.0×	9	1.1k
Jessica Moskovitz United States	10	732 0.9×	676 1.4×	231 1.0×	126 0.9×	110 0.8×	13	1.1k
Todd Bartkowiak United States	11	513 0.6×	637 1.3×	234 1.0×	96 0.7×	194 1.5×	21	963
Jae W. Lee United States	11	658 0.8×	455 0.9×	265 1.1×	76 0.5×	153 1.2×	29	1.0k
Akihiro Hosoi Japan	16	568 0.7×	592 1.2×	236 1.0×	158 1.1×	95 0.7×	30	928

Countries citing papers authored by W.E. Gillanders

Since Specialization

Citations

This map shows the geographic impact of W.E. Gillanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.E. Gillanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.E. Gillanders more than expected).

Fields of papers citing papers by W.E. Gillanders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.E. Gillanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.E. Gillanders. The network helps show where W.E. Gillanders may publish in the future.

Co-authorship network of co-authors of W.E. Gillanders

This figure shows the co-authorship network connecting the top 25 collaborators of W.E. Gillanders. A scholar is included among the top collaborators of W.E. Gillanders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.E. Gillanders. W.E. Gillanders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Kim, Sun Kyung, Feiya Ou, Stephen T. Ferris, et al.. (2023). IL-6 selectively suppresses cDC1 specification via C/EBPβ. The Journal of Experimental Medicine. 220(10). 16 indexed citations

2.

Goedegebuure, S. Peter, et al.. (2017). Preclinical and clinical development of neoantigen vaccines. Annals of Oncology. 28(suppl_12). xii11–xii17. 179 indexed citations

3.

Muenst, Simone, Feng Gao, Silvio Däster, et al.. (2014). Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer. Breast Cancer Research and Treatment. 146(1). 15–24. 462 indexed citations breakdown →

4.

Muenst, Simone, Savas D. Soysal, Feng Gao, et al.. (2013). The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer. Breast Cancer Research and Treatment. 139(3). 667–676. 274 indexed citations

5.

Soysal, Savas D., Simone Muenst, Thanh U. Barbie, et al.. (2013). EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer. British Journal of Cancer. 108(7). 1480–1487. 102 indexed citations

6.

Lepley, Denise, W.E. Gillanders, Nancy B. Myers, et al.. (1997). BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF SOLUBLE MULTIVALENT MHC Ld/Fc??1 AND Ld/Fc?? CHIMERIC PROTEINS LOADED WITH SPECIFIC PEPTIDES1. Transplantation. 63(5). 765–774. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact